Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…ed patients. Grade ≥3 irAEs are projected at 12,289 cases, with melanoma and RCC showing highest per-patient risks (30% and 25%, respect…
…Background Head and neck cancer remains the 6th most common cancer globally, with patients ofte…
…herapy, such as immune checkpoint inhibitors (ICI), outcomes of head and neck squamous cell carcinoma (HNSCC) remain suboptimal, with ICI response rates at ~17% in t…
…assessment characterizing the immunopeptidome of 10 HNSCC and 3 NSCLC cell lines derived from 9 different patients, revealed 74,578 u…
…ts with either Head and Neck squamous cell carcinoma (HNSCC) or Soft Tissue Sarcoma (STS). Following CIVO intratumoral microdose injections of PBA-…
…c data from seven cohorts spanning four cancer types (n = 314): melanoma; n=100, NSCLC; n=117, TNBC; n=42, and HNSCC; n=55. Each cancer …
…EX in patients with select advanced solid tumors. Patients with melanoma, NSCLC, HNSCC, CRC, pancreatic, and cervical cancer who have pr…
… were head and neck squamous cell carcinoma (n=6), melanoma and ovarian cancer (each n=4). A total of 83 treatment-emergent adverse events (TE…
…41 per cohort) with recurrent or metastatic non-small cell lung cancer (NSCLC), melanoma, endometrial cancers, or head and neck squamo…
…ansion study is evaluating CHS-114 in advanced solid tumors and head and neck squamous cell carcinoma (HNSCC). CHS-114 has demonstrated an acceptable safety profile …
…nd enable downstream activation of adaptive immune responses in solid tumors.Methods IMANs were generated via a proprietary, GMP-compliant d…
…ablished a new standard of care in resectable, locally advanced head and neck squamous cell carcinoma by integrating perioperative PD-1 blockade with surgery and (ch…